肿瘤化疗辅助药物研究进展
被引量:11
Progresses in the study of chemotherapy protectants
摘要
本文对 5 -羟色胺 3受体拮抗剂、集落刺激因子、双磷酸盐、氨磷汀以及白细胞介素 - 11等化疗辅助药物的研究进展作一综述。
出处
《国外医学(肿瘤学分册)》
2002年第1期21-25,共5页
Foreign Medical Sciences (Cancer Section)
参考文献16
-
1Perez EA, Lembersky B, Kaywin P, et al. Intravenous(IV) granisetron vs ondansetron in the prevention of cyclophosphamide-doxorubicin-induced emesis in breast cancer patients: a double blind crossover study[J]. Proc Am Soc Clin Oncol, 1996, 15: 543.
-
2Perez EA, Hesketh P, Sandbach J, et al. Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetngenic chemotherapy: a multicenter, double-blind, randimized parallel study[J]. J Clin Oncol, 1998, 16(2): 754-760.
-
3Navari R, Gandara D,Hesketh P,et al. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin induced emesis[J]. J Clin Oncol, 1995, 13(5): 1242-1248.
-
4Gralla RJ, Navari RM, Hesketh PJ, et al. Single-dose oral granisetron, has equivalent antiernetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based ehernotherapy[J]. J Clin Oncol, 1998, 16(4): 1568-1573.
-
5Anonymous. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy[J]. N Engl J Med, 2000, 342(21): 1554-1559.
-
6Crawford J, Ozer H, Stoller R, et al. Reduction by granuloeyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer (r-metHuC- CSF) [J]. N Engl J Med, 1991,325(3) : 164-170.
-
7Maher D, Green M, Bishop J, et al. Randomized, placebo controlled trial of filgrastim (r-metHuG-CSF) in patients with febrile neutropenia (FN)following chemotherapy(CT) [J]. Proc Am Soc Clin Oncol, 1993, 12: 434.
-
8Trillet Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy[J]. Eur J Cancer, 1993, 29A(3): 319-324.
-
9Gebbia V, Testa A, Valenza R, et al. A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma[J]. J Chemother, 1993, 5(3): 186-190.
-
10Hortobagyi GN, Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases[J]. N Engl J Med, 1996, 335(24): 1785-1791.
同被引文献68
-
1贾国洪,朱习琴,王珍,尚培中.肿瘤化疗药物及其辅助药物的合理应用[J].中国煤炭工业医学杂志,2004,7(6):488-489. 被引量:1
-
2姚连昌,杨仁杰.原发性肝癌化疗用药的现状与展望[J].临床肝胆病杂志,2005,21(1):62-64. 被引量:13
-
3胡夕春,蔡扬,杨新苗,李进.肿瘤化疗用药方法的研究进展[J].世界临床药物,2005,26(11):646-649. 被引量:19
-
4赫连鸿昌,朱佩茹,刘素华,麻会云.晚期肝癌肝动脉灌注化疗(附43例)[J].现代肿瘤医学,2006,14(10):1306-1306. 被引量:1
-
5何流 张宏星 等.应用国产特尔立治疗肿瘤化疗所致白细胞减少的疗效观察[J].实用临床医学,1999,13(4):22-24.
-
6Leung TW,Tang AM,Zee B,et al.Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin,interferon-alpha,doxorubicin and 5-fluorouracil chemotherapy[J].Cancer,2002,94(9):421-427.
-
7Kanmematsu T.Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma[J].Hepato Gastroenterol,1996,4(3):1404-1405.
-
8Poon RT,Ngan H,Lo CM,et al.Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence[J].J Surg Oncol,2000,73(2):109-114.
-
9Nakashima K,Kinno S,Kim YI,et al.Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma[J].Hepato-gastrorenterology,1996,43(12):1410-1414.
-
10TakagiK,Koyama T,Hasegawa M.et al.The effect of hepatic arteiral infusion chemotherapy on the prognosis after heparectomy for hepatocellular carcinoma[J].Gan To Kagaku Rycho.1998,25(4):597.
引证文献11
-
1孙祥,姚荣杰,李成发.非小细胞肺癌50例化疗临床观察[J].中国临床保健杂志,2004,7(3):208-208.
-
2周晓军,郝传铮,姜秀芹,许春明,邱洪贵.止呕神贴治疗恶性肿瘤化疗所致呕吐临床观察与实验研究[J].甘肃中医,2004,17(12):44-46. 被引量:2
-
3吴力乐,苗雄鹰,文宇.肝癌辅助化疗的研究[J].中南药学,2009,7(2):129-132. 被引量:3
-
4罗文基,黄丽娟,陈逸生.临床用药辅助治疗恶性肿瘤的现状调查与分析[J].中国实用医药,2011,6(24):172-174. 被引量:11
-
5吴俊,顾敏,宋楷,倪美鑫,宇传华.抗肿瘤辅助药物管理系统开发应用[J].中国数字医学,2013,8(2):14-16. 被引量:4
-
6夏爱晓,孙渊.临床药师对血液肿瘤科药物治疗的药学监护[J].海峡药学,2015,27(1):116-120. 被引量:1
-
7旋静,高金良.肿瘤化疗辅助用药的临床发展概况[J].中国医药指南,2015,13(15):51-52. 被引量:5
-
8郭梦园,邱爽,崔向丽,刘丽宏.临床药师对1例复发难治多发性骨髓瘤患者开展的药学服务[J].临床药物治疗杂志,2017,15(3):55-59. 被引量:3
-
9姚亚萍,朱亚芳,魏金芝.格宁治疗肿瘤化疗后白细胞减少的疗效观察[J].交通医学,2002,16(5):520-521.
-
10罗莎莉,黄芳,崔玉珍,沈韵.肝动脉化疗栓塞术前、后静脉应用止吐药物的临床研究[J].解放军护理杂志,2003,20(7):28-30. 被引量:14
二级引证文献45
-
1蔡伯琴,王甦.肝癌介入治疗并发症的观察与护理[J].黑龙江医药,2009,22(6):930-931. 被引量:1
-
2郑颖怀.经肝动脉和门静脉化疗泵治疗肝癌的护理[J].当代护士(下旬刊),2010,17(S1):37-38. 被引量:1
-
3黄爱梅,罗莎莉.肝癌介入治疗病人生存质量的影响因素及其护理[J].护理研究(上旬版),2005,19(9):1701-1704. 被引量:10
-
4滕红,陈世沛,陈友琼,徐兴明.联合方案预防肝癌介入化疗所致恶心呕吐的疗效观察[J].四川医学,2006,27(3):271-272. 被引量:9
-
5陈莺,杨伟琴,吴建新.肝动脉化疗栓塞后急性上消化道出血的相关因素及护理[J].解放军护理杂志,2006,23(6):34-35. 被引量:12
-
6黄爱梅.肝癌介入术后并发症的治疗和护理进展[J].护理研究(中旬版),2006,20(12):3211-3213. 被引量:36
-
7罗莎莉,谢永丽,李惠惠.肝动脉化疗栓塞后电解质和肝功能指标的变化[J].护理研究(上旬版),2008,22(1):58-60. 被引量:3
-
8宋林萍,张云杰,周晓英,李慧,付嫱.肿瘤患者血细胞分离治疗中不同补钙时机与方式的探讨[J].护理学报,2008,15(10):26-27. 被引量:1
-
9张艳新.肝动脉灌注栓塞术后常见并发症原因与护理[J].临床误诊误治,2008,21(11):81-83. 被引量:3
-
10卢笑娟.肝癌介入治疗期间病人的的预见性护理[J].全科护理,2010,8(5):408-409. 被引量:9
-
1赵文亮,康马飞.外周血白细胞介素-11表达在非小细胞肺癌患者中的意义[J].重庆医学,2016,45(21):2985-2987. 被引量:1
-
2任丽,陈瑛,张鹏宇,齐寰宇.白细胞介素-11结缔组织生长因子对乳腺癌骨转移的诊断价值分析[J].中国肿瘤临床,2010,37(17):988-990.
-
3崔中光,汪洪毅.巨和粒治疗急性白血病化疗后血小板减少疗效观察[J].山东医药,2005,45(4):77-77.
-
4朱淑姣,王绍明,母凯平,叶绿.枢丹预防化疗引起胃肠道反应的疗效观察[J].吉林医学,2003,24(4):371-372.
-
5王理扬,蒙荣钦,张瑜,黄媚娟.重组人血小板生成素治疗肿瘤化疗后血小板减少的临床观察[J].华西医学,2010,25(9):1686-1688. 被引量:13
-
6夏志军,张淑兰,张忠福.化疗辅助药物对卵巢癌患者癌因性疲乏的改善[J].中国临床康复,2003,7(1):97-98. 被引量:1
-
7陈占红,黄健,楼彩金,王晓稼.白细胞介素-11治疗恶性肿瘤化疗后血小板减少的临床研究[J].国际肿瘤学杂志,2006,33(8).
-
8赵旭林.rhIL-11对恶性肿瘤化疗引起血小板减少的治疗作用[J].中外医疗,2011,30(12):40-40. 被引量:2
-
9张秋霞.白细胞介素-11治疗化疗所致血小板减少的临床观察[J].河南肿瘤学杂志,2004,17(4):298-298.
-
10杨乐伟,孙玉勤,陈嘉洛,杨光伟.白细胞介素-11雾化吸入治疗鼻咽癌同期放化疗导致口腔黏膜炎的疗效观察[J].中国医药科学,2014,4(8):20-22. 被引量:5